ATG-201

ATG-201 is a novel T-cell engager (TCE). ATG-201 exhibits CD19-dependent CD3 binding and activation properties, enabling the effective depletion of B cells. ATG-201 can be used to study B-cell malignancies and B-cell-related autoimmune diseases.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Almacenamiento:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Actividad biológica
  • Chemical Information
  • Protocolo
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00